Beyond the Sglt2-Cre; ASPSCR1-TFE3LSL/+ model, we expand the number of available tRCC models through the characterization of several TGs in our collection (26). This evidence concerns the gene ASPSCR1 and renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.